CBIO

Catalyst Biosciences (CBIO)

Catalyst Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CBIO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/03	07 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/05/02	05 : 51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/29	21 : 49	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/29	21 : 48	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/29	21 : 46	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/20	05 : 06	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/10	05 : 31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/09	07 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/06	06 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/05	06 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/04	05 : 48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/04	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/03	06 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/04/02	07 : 42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/27	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/26	10 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/22	09 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/22	09 : 27	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/21	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/20	05 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/03/16	06 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/02/15	07 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/01/25	07 : 11	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CBIO	Catalyst Biosciences Inc
2024/01/13	06 : 01	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CBIO	Catalyst Biosciences Inc
2023/12/16	06 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CBIO	Catalyst Biosciences Inc
2023/12/07	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CBIO	Catalyst Biosciences Inc
2023/11/30	06 : 01	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:CBIO	Catalyst Biosciences Inc
2023/11/28	06 : 49	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:CBIO	Catalyst Biosciences Inc
2023/11/23	09 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CBIO	Catalyst Biosciences Inc